Identifying Angiogenic Factors in Pediatric Choroid Plexus Papillomas
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Choroid plexus papillomas (CPPs) in children show increased angiogenic factors like VEGF-A. These factors promote blood vessel growth, suggesting angiogenesis is key to CPP development and a potential therapeutic target.
Area Of Science
- Neuro-oncology
- Vascular Biology
- Pediatric Oncology
Background
- Choroid plexus papillomas (CPPs) are rare pediatric brain tumors with unknown development mechanisms.
- Angiogenesis, the formation of new blood vessels, is implicated in other brain tumors.
- This study investigates angiogenesis as a potential hallmark of CPP biology.
Purpose Of The Study
- To identify and validate angiogenic factors in Choroid Plexus Papillomas (CPPs).
- To explore the role of angiogenesis in the development of pediatric brain tumors.
Main Methods
- Cerebrospinal fluid (CSF) and tumor samples were collected from CPP patients.
- Multiplex immunoassay and proteome blot arrays identified differentially expressed cytokines.
- Patient-derived cell cultures and HUVEC angiogenesis assays validated angiogenic factor activity.
Main Results
- CSF analysis revealed elevated levels of VEGF-A, MCP-1, MMP-1, TNF-α, and CD40L in CPP patients.
- CPP cell lines and supernatants showed increased expression of VEGF, MCP-1, and MMP-1.
- HUVEC assays confirmed that CPP-conditioned media promotes angiogenesis.
Conclusions
- This study provides evidence that angiogenesis is a significant factor in Choroid Plexus Papillomas.
- Identified angiogenic factors (VEGF, MCP-1, MMP-1) represent potential therapeutic targets for CPPs.
- Further research into CPP angiogenesis is warranted.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...